BrightPath Biotherapeutics4594 
$0.36-1.92%24h
-1.92%24h
Global rank29455
Market cap$21.41M
Change 7d0.00%
YTD Performance-40.70%
SP500 benchmarkUnderperform
P/E-0.01
P/S576.26
Revenue$37.16K
Earnings-$10.45M
Dividend yield-
BrightPath Biotherapeutics (4594) Total Liabilities
4594 Total Liabilities in 2022: $942.33K
According to BrightPath Biotherapeutics latest financial reports the total liabilities of 4594 is $942.33K, an decrease of -44.14% to 2022. At the end of 2022 company had $1.69M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that BrightPath Biotherapeutics is responsible for during its operational activities.
BrightPath Biotherapeutics (4594) Total Liabilities History from 2023 to 2022
-
Value:-
4594 Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $942.33K | -44.14% |
| 2022 | $1.69M | 13.19% |
| 2021 | $1.49M | -11.54% |
| 2020 | $1.68M | 589.50% |
| 2019 | $244.34K | - |
View the Top Total Liabilies Stocks
